Developer docs
API playgroundTry for free, no card

Search company profiles

Transplant Connect

Full company profile

uuid0008vmh

Namestring
Transplant Connect
Legal namestring
Transplant Connect
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Transplant Connect is a US-based medical software company that builds the iTransplant platform for the organ, eye, tissue, and birth tissue donation-transplant workflow. Its software is deployed by hospitals, transplant centers, and organ procurement organizations to manage donor registration, organ matching, transplant coordination, and chain-of-custody for tissue implants, with RFID-based tracking for hospital tissue implant software. Complementary modules include iReferral, an automated donor referral engine, and the iTransplant Mobile App, which provides HIPAA-compliant chat, image sharing, and team geo-tracking for field transplant staff.

The company was founded in 2004 by John Piano and has operated for approximately two decades as a specialist vendor in a narrow clinical vertical. In 2022 it received investment from InVita Healthcare Technologies, and in 2023 it was fully integrated as InVita's Donation-Transplant division, gaining access to broader R&D capacity and cross-sell opportunities into InVita's adjacent human biologics software (blood center, DNA, hospital tissue implant). Following the integration, founder John Piano moved into a strategic role on the InVita executive team and board, and Wade Liu was promoted to Chief Product Officer of InVita and General Manager of the Donation-Transplant division.

Transplant Connect operates as a B2B enterprise software business serving regulated healthcare buyers. Its go-to-market is direct enterprise sales to hospitals and OPOs; pricing is not publicly disclosed. The business model is consistent with vertical SaaS in a mission-critical, regulated workflow: high switching costs, long deployment cycles, and expansion revenue driven by module attach (iReferral, mobile app, RFID) rather than new logo acquisition, given the small universe of US OPOs and transplant centers.

Short descriptiontext

Transplant Connect builds the iTransplant software platform for organ, eye, tissue, and birth tissue donation-transplant workflows, serving hospitals, transplant centers, and organ procurement organizations as the donation-transplant division of InVita Healthcare Technologies.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSanta Monica, United States
HQ citystring
Santa Monica
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
donation-transplant software, organ procurement software, tissue implant tracking, donor referral automation, healthcare biologics software
Industry1 code
1Connected Therapeutics & Smart Drug Delivery Monitoring
CodeHLACAFALPrimaryYes
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Health Services8000
Product category
Healthcare Donation-Transplant Software
Social media profiles1 record
Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1iTransplant
Description

Industry-leading and award-winning Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform.

campaign.invitahealth.com:443
+2 more records
Core offering1 text field

Transplant Connect develops and sells the iTransplant Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform, a comprehensive software solution for managing donor registration, organ matching, and transplant workflows. The offering is complemented by the iReferral automated donor referral module and the iTransplant Mobile App, which provides HIPAA-compliant chat, image sharing, and logistics/team geo-tracking for field transplant teams. The platform is sold to hospitals, transplant centers, and other healthcare organizations to connect and streamline the donation-transplant ecosystem.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Transplant Connect operates as the Donation-Transplant division under InVita Healthcare Technologies, offering a unified product ecosystem centered on the iTransplant Platform. The core offering is the iTransplant Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform, complemented by the iReferral automated donor referral module and the iTransplant Mobile App. Together, these products connect and streamline the donation-transplant ecosystem, enabling partners to manage organ, eye, tissue, and birth tissue donation workflows through a comprehensive digital solution.

Product and service3 records
1iTransplant Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform
2iReferral Automated Donor Referral Technology
3iTransplant Mobile App
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Provides real-time organ transportation and logistics technology to OPOs and transplant centers. Comparable to Transplant Connect because both serve the same donation-transplant customer base with mission-critical software, though MediGO focuses on logistics while Transplant Connect focuses on donor/recipient workflow.

TypeDirect peer
Description

Blood center and biologics management software vendor that operates alongside Transplant Connect under the InVita Healthcare Technologies umbrella. Comparable as a sibling product serving adjacent human biologics workflows for hospitals and blood centers.

TypeBroad incumbent
Description

Dominant US hospital EHR vendor whose systems underpin the IT estates of most transplant centers. Comparable as the broad incumbent platform that Transplant Connect must integrate with and against which it must justify standalone spend.

TypeBroad incumbent
Description

Major hospital EHR vendor with deep penetration in large health systems and academic transplant centers. Comparable as a broad incumbent whose transplant-adjacent workflows could expand to encroach on Transplant Connect's niche.

TypeBroad incumbent
Description

Hospital EHR vendor serving community and mid-size hospitals, including transplant programs. Comparable as a broad incumbent EHR that Transplant Connect integrates with at the hospital level.

TypeBroad incumbent
Description

Blood and plasma component management company with software and hardware solutions for hospital transfusion services. Comparable as a broader human biologics vendor serving adjacent workflows that Transplant Connect touches via InVita's blood center unit.

TypeEmerging player
Description

Transplant diagnostics and digital health company serving transplant centers and post-transplant patients. Comparable as a focused transplant ecosystem player whose center-facing software strategy overlaps with Transplant Connect's hospital customer base.

TypeEmerging player
Description

Medical device company developing organ preservation technology (metra) used during transplant logistics. Comparable as a transplant-ecosystem technology vendor whose success drives transplant volumes that benefit Transplant Connect's platform.

TypeEmerging player
Description

Organ transplant systems company providing OCS (Organ Care System) technology for lung, heart, and liver preservation and transport. Comparable as a transplant-ecosystem technology vendor whose growth expands the underlying transplant market Transplant Connect serves.

TypeOthers
Description

Specialty pharma company focused on transplant immunosuppression (Envarsus XR). Comparable as an adjacent transplant-ecosystem participant serving the same end-clinicians and transplant centers, though via therapeutics rather than software.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Transplant Connect

Healthcare Donation-Transplant Softwaretransplantconnect.com

Transplant Connect builds the iTransplant software platform for organ, eye, tissue, and birth tissue donation-transplant workflows, serving hospitals, transplant centers, and organ procurement organizations as the donation-transplant division of InVita Healthcare Technologies.

What Transplant Connect does

Transplant Connect is a US-based medical software company that builds the iTransplant platform for the organ, eye, tissue, and birth tissue donation-transplant workflow. Its software is deployed by hospitals, transplant centers, and organ procurement organizations to manage donor registration, organ matching, transplant coordination, and chain-of-custody for tissue implants, with RFID-based tracking for hospital tissue implant software. Complementary modules include iReferral, an automated donor referral engine, and the iTransplant Mobile App, which provides HIPAA-compliant chat, image sharing, and team geo-tracking for field transplant staff.

The company was founded in 2004 by John Piano and has operated for approximately two decades as a specialist vendor in a narrow clinical vertical. In 2022 it received investment from InVita Healthcare Technologies, and in 2023 it was fully integrated as InVita's Donation-Transplant division, gaining access to broader R&D capacity and cross-sell opportunities into InVita's adjacent human biologics software (blood center, DNA, hospital tissue implant). Following the integration, founder John Piano moved into a strategic role on the InVita executive team and board, and Wade Liu was promoted to Chief Product Officer of InVita and General Manager of the Donation-Transplant division.

Transplant Connect operates as a B2B enterprise software business serving regulated healthcare buyers. Its go-to-market is direct enterprise sales to hospitals and OPOs; pricing is not publicly disclosed. The business model is consistent with vertical SaaS in a mission-critical, regulated workflow: high switching costs, long deployment cycles, and expansion revenue driven by module attach (iReferral, mobile app, RFID) rather than new logo acquisition, given the small universe of US OPOs and transplant centers.

Transplant Connect firmographics

Firmographics
Name
Transplant Connect
Legal name
Transplant Connect
Website
https://transplantconnect.com
Company type
Private
Founded year
2004
Operating status
Acquired
Headcount range
11–50 employees
Short description
Transplant Connect builds the iTransplant software platform for organ, eye, tissue, and birth tissue donation-transplant workflows, serving hospitals, transplant centers, and organ procurement organizations as the donation-transplant division of InVita Healthcare Technologies.
Ownership category
akta.pro rank

Transplant Connect industry classification

Industry
Product category
Healthcare Donation-Transplant Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Health Services (8000)
akta.pro primary industry
Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

Keywords

  • Donation-transplant software
  • Organ procurement software
  • Tissue implant tracking
  • Donor referral automation
  • Healthcare biologics software

Where Transplant Connect is headquartered

Location

Headquarters

HQ city
Santa Monica
HQ country
United States
HQ region
North America

Markets served

Transplant Connect business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Transplant Connect product offering

Product offering

Core offering

Transplant Connect develops and sells the iTransplant Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform, a comprehensive software solution for managing donor registration, organ matching, and transplant workflows. The offering is complemented by the iReferral automated donor referral module and the iTransplant Mobile App, which provides HIPAA-compliant chat, image sharing, and logistics/team geo-tracking for field transplant teams. The platform is sold to hospitals, transplant centers, and other healthcare organizations to connect and streamline the donation-transplant ecosystem.

Product overview

Transplant Connect operates as the Donation-Transplant division under InVita Healthcare Technologies, offering a unified product ecosystem centered on the iTransplant Platform. The core offering is the iTransplant Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform, complemented by the iReferral automated donor referral module and the iTransplant Mobile App. Together, these products connect and streamline the donation-transplant ecosystem, enabling partners to manage organ, eye, tissue, and birth tissue donation workflows through a comprehensive digital solution.

Differentiator

Problem solved

Functional benefit

Brands

  • iTransplant: Industry-leading and award-winning Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform.
  • iReferral
  • iTransplant Mobile App

Products and services

  • iTransplant Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform
  • iReferral Automated Donor Referral Technology
  • iTransplant Mobile App

Companies that use Transplant Connect

Customer profile

Segments1 record

Ideal customer profiles1 record

Transplant Connect technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Transplant Connect partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights5 records

Transplant Connect competitors and assessment

Company assessment

Direct peers

  • MediGO: Provides real-time organ transportation and logistics technology to OPOs and transplant centers. Comparable to Transplant Connect because both serve the same donation-transplant customer base with mission-critical software, though MediGO focuses on logistics while Transplant Connect focuses on donor/recipient workflow.
  • LifeLogics: Blood center and biologics management software vendor that operates alongside Transplant Connect under the InVita Healthcare Technologies umbrella. Comparable as a sibling product serving adjacent human biologics workflows for hospitals and blood centers.

Broad incumbents

  • Epic Systems: Dominant US hospital EHR vendor whose systems underpin the IT estates of most transplant centers. Comparable as the broad incumbent platform that Transplant Connect must integrate with and against which it must justify standalone spend.
  • Oracle Health (Cerner): Major hospital EHR vendor with deep penetration in large health systems and academic transplant centers. Comparable as a broad incumbent whose transplant-adjacent workflows could expand to encroach on Transplant Connect's niche.
  • MEDITECH: Hospital EHR vendor serving community and mid-size hospitals, including transplant programs. Comparable as a broad incumbent EHR that Transplant Connect integrates with at the hospital level.
  • Haemonetics: Blood and plasma component management company with software and hardware solutions for hospital transfusion services. Comparable as a broader human biologics vendor serving adjacent workflows that Transplant Connect touches via InVita's blood center unit.

Emerging players

  • CareDx: Transplant diagnostics and digital health company serving transplant centers and post-transplant patients. Comparable as a focused transplant ecosystem player whose center-facing software strategy overlaps with Transplant Connect's hospital customer base.
  • OrganOx: Medical device company developing organ preservation technology (metra) used during transplant logistics. Comparable as a transplant-ecosystem technology vendor whose success drives transplant volumes that benefit Transplant Connect's platform.
  • TransMedics: Organ transplant systems company providing OCS (Organ Care System) technology for lung, heart, and liver preservation and transport. Comparable as a transplant-ecosystem technology vendor whose growth expands the underlying transplant market Transplant Connect serves.

Others

  • Veloxis Pharmaceuticals: Specialty pharma company focused on transplant immunosuppression (Envarsus XR). Comparable as an adjacent transplant-ecosystem participant serving the same end-clinicians and transplant centers, though via therapeutics rather than software.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Transplant Connect social profiles

Digital presence

Transplant Connect financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Transplant Connect leadership team

Management profile

Number of profiles

Profiles2 records

Transplant Connect funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Transplant Connect M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Transplant Connect

What does Transplant Connect do?

Transplant Connect develops and sells the iTransplant Organ, Eye, Tissue and Birth Tissue Donation-Transplant Platform, a comprehensive software solution for managing donor registration, organ matching, and transplant workflows. The offering is complemented by the iReferral automated donor referral module and the iTransplant Mobile App, which provides HIPAA-compliant chat, image sharing, and logistics/team geo-tracking for field transplant teams. The platform is sold to hospitals, transplant centers, and other healthcare organizations to connect and streamline the donation-transplant ecosystem.

Is Transplant Connect a public or private company?

Transplant Connect is a private company. It is classified as corporate owned and is currently acquired.

When was Transplant Connect founded?

Transplant Connect was founded in 2004. It employs 11 to 50 people.

Where is Transplant Connect based?

Transplant Connect is headquartered in Santa Monica, United States, in the North America region.

Who are Transplant Connect's main competitors?

Direct peers on record are MediGO and LifeLogics. Broad incumbents are Epic Systems, Oracle Health (Cerner), MEDITECH and Haemonetics. Emerging players are CareDx, OrganOx and TransMedics. Veloxis Pharmaceuticals is listed as an others.

Does Transplant Connect have an API?

No public API is recorded for Transplant Connect.

What industry is Transplant Connect in?

Transplant Connect's product category is Healthcare Donation-Transplant Software. Its primary akta.pro industry code is HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 54151 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTransplant Connect and Cerner streamline organ donation and transplant processTransplant Connect and Cerner announced a collaboration to launch an automated organ donor referral system that integrates Cerner Millennium EHR with Transplant Connect's iReferral technology, replacing the traditional phone-based referral process. The system enables near real-time donor identification and referral to organ-procurement organizations, with Transplant Connect's platform currently used by 74% of U.S. OPOs and approximately 4,500 hospitals across the country. The companies expect this automation to reduce caregiver administrative burden, decrease errors from manual data transfer, and ultimately increase successful organ transplants, with initial deployment at five hospitals.PR NewswireNewYork-Presbyterian, LiveOnNY and Transplant Connect Launch iReferral(SM) Automated Donor Referral Technology to Increase Donation and Transplantation across New York CityNewYork-Presbyterian, LiveOnNY, and Transplant Connect have launched iReferral, an automated technology that streamlines organ donor referrals within the greater New York City area. The system integrates with electronic health records to notify nurses of potential donors and enables secure, rapid electronic transmission of referrals, reducing the process time from 20-30 minutes to seconds. This initiative is currently active across seven NewYork-Presbyterian hospital campuses to improve workflow efficiency and potentially increase transplantation rates.PR NewswireCleveland Clinic, Lifebanc and Transplant Connect Develop Automated Donor Referral ProcessCleveland Clinic, Lifebanc, and Transplant Connect have launched an automated donor referral system to streamline the identification and evaluation of potential organ donors. The new process replaces labor-intensive manual phone calls with secure, automatic data transmission from hospital electronic medical records to the Organ Procurement Organization's systems. This deployment marks the largest rollout of such automated technology to date, aiming to improve workflow efficiency and increase donation rates.PR NewswireNew electronic interface will ultimately save more livesOn October 9, 2018, Southwest Transplant Alliance (STA), CHRISTUS Mother Frances Hospital - Tyler in Texas, and Transplant Connect launched a first-of-its-kind electronic interface called iReferral, which automatically notifies STA of potential organ and tissue donors by integrating with the hospital's Epic EMR system. The platform replaces manual, time-consuming phone calls with real-time automated referrals, freeing hospital nursing staff to focus on direct patient care while reducing the risk of human error or delays in the donation process. The organizations plan to closely monitor the system in the coming months with the goal of a broader national rollout to additional STA hospitals and other organ procurement organizations.